Correlation Between Ikena Oncology and Hookipa Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and Hookipa Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and Hookipa Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and Hookipa Pharma, you can compare the effects of market volatilities on Ikena Oncology and Hookipa Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of Hookipa Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and Hookipa Pharma.

Diversification Opportunities for Ikena Oncology and Hookipa Pharma

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between Ikena and Hookipa is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and Hookipa Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hookipa Pharma and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with Hookipa Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hookipa Pharma has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and Hookipa Pharma go up and down completely randomly.

Pair Corralation between Ikena Oncology and Hookipa Pharma

Given the investment horizon of 90 days Ikena Oncology is expected to generate 0.33 times more return on investment than Hookipa Pharma. However, Ikena Oncology is 3.02 times less risky than Hookipa Pharma. It trades about 0.08 of its potential returns per unit of risk. Hookipa Pharma is currently generating about -0.52 per unit of risk. If you would invest  169.00  in Ikena Oncology on August 24, 2024 and sell it today you would earn a total of  4.00  from holding Ikena Oncology or generate 2.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ikena Oncology  vs.  Hookipa Pharma

 Performance 
       Timeline  
Ikena Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ikena Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Ikena Oncology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Hookipa Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hookipa Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Ikena Oncology and Hookipa Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ikena Oncology and Hookipa Pharma

The main advantage of trading using opposite Ikena Oncology and Hookipa Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, Hookipa Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hookipa Pharma will offset losses from the drop in Hookipa Pharma's long position.
The idea behind Ikena Oncology and Hookipa Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets